| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Vol. 135, No. 12: 1358-1367
Copyright © 1992 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Influence of the Mother's Prenatal Drug Consumption on Risk of Neuroblastoma in the Child
From the Department of Preventive Medicine, The Ohio State University Columbus, OH
Reprint requests to Dr Judith A. Schwartzbaum, Department of Preventive Medicine, The Ohio State University, Starling Loving Hall, 320 West 10th Avenue, Columbus, OH 43210–1240
A case-control study was conducted 1) to determine whether maternal prenatal drug consumption increases the risk of neuroblastoma in the child and, if so, 2) to see if the size of the risk depends on whether the case is inherited or sporadic. Mothers of children with newly diagnosed neuroblastoma (n = 101) were compared with mothers of children newly diagnosed with other forms of childhood cancer (n = 690). Cases and controls were selected from the population of childhood cancer patients at St. Jude Children’s Research Hospital, Memphis, Tennessee, between 1979 and 1986. The patients‘ mothers were interviewed to ascertain their prenatal medication, alcohol, and tobacco consumption patterns. Unconditional logistic regression models were used to adjust for maternal age at birth, patient age at diagnosis, race, social class, exposure to x-ray, miscarriage, and other confounding variables. Adjusted odds ratios were estimated for the total sample and for subgroups that had a higher probability of containing inherited cases. Drugs associated with neuroblastoma case status include diuretics for hypertension (odds ratio (OR) = 4.1, 95 percent confidence interval (Cl) 1.0–16.9), tranquilizers (OR = 2.1, 95 percent Cl 1.1–4.3), nonprescription pain relievers (OR = 1.9, 95 percent Cl 1.1–3.1), and cigarettes (OR = 1.9, 95 percent Cl 1.1–3.2). The odds ratios for maternal prenatal drug consumption for the group with inherited cases and the total sample were approximately the same. This equality is inconsistent with predictions based on Knudson’s two-stage model of carcinogenesis. Am J Epidemiol 1992; 135: 1358–67
case-control studies; diuretics; fetus; genetics; neuroblastoma; tranquilizing agents
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. N. Cook, A. F. Olshan, H. A. Guess, D. A. Savitz, C. Poole, J. Blatt, M. L. Bondy, and B. H. Pollock Maternal Medication Use and Neuroblastoma in Offspring Am. J. Epidemiol., April 15, 2004; 159(8): 721 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Klip, C. W. Burger, J. de Kraker, and F. E. van Leeuwen Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF Hum. Reprod., November 1, 2001; 16(11): 2451 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Yang, A. F. Olshan, M. L. Bondy, N. R. Shah, B. H. Pollock, R. C. Seeger, A. T. Look, and S. L. Cohn Parental Smoking and Alcohol Consumption and Risk of Neuroblastoma Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 967 - 972. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. J Sasco and H. Vainio From in utero and childhood exposure to parental smoking to childhood cancer: a possible link and the need for action Human and Experimental Toxicology, April 1, 1999; 18(4): 192 - 201. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Ross and S. M. Davies Screening for Neuroblastoma: Progress and Pitfalls Cancer Epidemiol. Biomarkers Prev., February 1, 1999; 8(2): 189 - 194. [Full Text]
|
|